(NasdaqGM:LFMD), NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. (“LifeMD, Inc.” or the “Company”) (NASDAQ: LFMD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of LifeMD, Inc. investors who were adversely affected by alleged securities fraud between May […]

Global Women's Health Rehabilitation Products Market Size/Share Worth USD 9.8 Billion by 2034 at a 6.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Women's Health Rehabilitation

Levi & Korsinsky Reminds PubMatic, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 20, 2025 – PUBM GlobeNewswire October 09, 2025 NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in PubMatic, Inc. (“PubMatic, Inc.” or the “Company”) (NASDAQ: PUBM) of a class

Blue Biofuels Concludes Department of Energy Phase 2 SBIR Grant GlobeNewswire October 09, 2025 Advancing Toward Commercialization PALM BEACH GARDENS, FL, Oct. 09, 2025 (GLOBE NEWSWIRE) — Blue Biofuels, Inc. (OTCQB: BIOF). Blue Biofuels is pleased to announce the successful completion of its Phase 2 Small Business Innovation Research (SBIR) grant awarded by the U.S.

LifeMD, Inc. Class Action: Levi & Korsinsky Reminds LifeMD, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 25, 2025 – LFMD GlobeNewswire October 09, 2025 NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. (“LifeMD, Inc.” or the “Company”) (NASDAQ:

Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome GlobeNewswire October 09, 2025 – An analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed continuing improvements in cognition and

(NASDAQ:FLYE), NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Fly-E Group, Inc. (“Fly-E” or the “Company”) (NASDAQ: FLYE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fly-E investors who were adversely affected by alleged securities fraud between July 15,

November 10, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against FLYE GlobeNewswire October 09, 2025 NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Fly-E Group, Inc. (“Fly-E” or the “Company”) (NASDAQ: FLYE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to

(NASDAQ:CHTR), NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Charter Communications, Inc. (“Charter Communications, Inc.” or the “Company”) (NASDAQ: CHTR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Charter Communications, Inc. investors who were adversely affected by alleged securities

Trading resumes in: Company: Aritzia Inc. TSX Symbol: ATZ All Issues: Yes Resumption (ET): 4:30 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees